Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 33, 2003 - Issue 9
237
Views
37
CrossRef citations to date
0
Altmetric
Research Article

Expression of drug-metabolizing enzymes, nuclear transcription factors and ABC transporters in Caco-2 cells

&
Pages 927-943 | Published online: 22 Sep 2008

Reference

  • ANDERLE, P., NIEDERER, E., RUBAS, W., HILGENDORF, C., SPAHN-LANGGUTH, H., WUNDERLI-ALLENSPACH, H., MERKLE, H. P. and LANGGUTH, P., 1998, P-glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels. Journal of Pharmaceutical Sciences, 87, 757–762.
  • ARLOTTO, M. P., TRANT, J. M. and ESTABROOK, R. W., 1991, Measurement of steroid hydroxylation reactions by high-performance liquid chromatography as indicator of P450 identity and function. Methods in Enzymology, 206, 454–462.
  • ARTURSSON, P., 1990, Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. Journal of Pharmaceutical Sciences, 79, 476–482.
  • BARANCZYK-KUZMA, A., OARREN, J. A., HIDALGO, I. J. and BORCHARDT, R. T., 1991, Substrate specificity and some properties of phenol sulfotransferase from human intestinal Caco-2 cells. Life Sciences, 49, 1197–1206.
  • BERTILSSON, P. M., OLSSON, P. and MAGNUSSON, K. E., 2001, Cytokines influence mRNA expression of cytochrome P450 3A4 and MDRI in intestinal cells. Journal of Pharmaceutical Sciences, 90, 638–646.
  • BJORGE, S., HAMELEHLE, K. L., HOMAN, R., ROSE, S. E., TURLUCK, D. A. and WRIGHT, D. S., 1991, Evidence for glucuronide conjugation of p-nitrophenol in the Caco-2 cell model. Pharmaceutical Research, 8, 1441–1443.
  • BORLAK, J. and Thum, T., 2001, Induction of nuclear transcription factors, cytochrome P450 monooxygenases, and glutathione S-transferase alpha gene expression in Aroclor 1254-treated rat hepatocyte cultures. Biochemical Pharmacology, 61, 145–153.
  • BOULENC, X., BOURRIE, M., FABRE, I., ROQUE, C., JOYEUX, H., BERGER, Y. and FABRE, G., 1992, Regulation of cytochrome P450IA1 gene expression in a human intestinal cell line, Caco-2. Journal of Pharmacology and Experimental Therapeutics, 263, 1471–1478.
  • CARRIERE, V., LESUFFLEUR, T., BARBAT, A., ROUSSET, M., DUSSAULX, E., COSTET, P., DE WAZIERS, I., BEAUNE, P. and ZWEIBAUM, A., 1994, Expression of cytochrome P-450 3A in HT29-MTX cells and Caco-2 clone TC7. FEBS Letters, 355, 247–250.
  • CARRIERE, V., RODOLOSSE, A., LACASA, M., CAMBIER, D., ZWEIBAUM, A. and ROUSSET, M., 1998, Hypoxia and CYP1A1 induction-dependent regulation of proteins involved in glucose utilization in Caco-2 cells. American Journal of Physiology, 274, G1101—G1108.
  • DAUJAT, M., CHARRASSE, S., FABRE, I., LESCA, P., JOUNAIDI, Y., LARROQUE, C., POELLINGER, L. and MAUREL, P., 1996, Induction of CYP1A1 gene by benzimidazole derivatives during Caco-2 cell differentiation. Evidence for an aryl-hydrocarbon receptor-mediated mechanism. European Journal of Biochemistry, 237, 642–652.
  • DE WAZIERS, I., CUGNENC, P. H., BERGER, A., LEROUX, J. P. and BEAUNE, P. H., 1991, Drug-metabolizing enzyme expression in human normal, peritumoral and tumoral colorectal tissue samples. Carcinogenesis, 12, 905–909.
  • DIETER, M. Z., FRESHWATER, S. L., SOLIS, W. A., NEBERT, D. W. and DALTON, T. P., 2001, Tyrphostin [correction of Tryphostin] AG879, a tyrosine kinase inhibitor: prevention of transcriptional activation of the electrophile and the aromatic hydrocarbon response elements. Biochemical Pharmacology, 61, 215–225.
  • DREWES, T., SENKEL, S., HOLEWA, B. and RYFFEL, G. U., 1996, Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes. Molecular Cell Biology, 16, 925–931.
  • ERICKSON, R. H., LAI, R. S. and KIM, Y. S., 2000, Role of hepatocyte nuclear factor lalpha and lbeta in the transcriptional regulation of human dipeptidyl peptidase IV during differentiation of Caco-2 cells. Biochemical and Biophysical Research Communications, 270, 235–239.
  • OUIGAL, N., SERE E., BOURGAREL-REY, V. and BARRA, Y., 2000, Induction of CYP1A1 by serum independent of AhR pathway. Biochemical and Biophysical Research Communications, 267, 572–576.
  • HARA, H., MITANI, N. and ADACHI, T., 2000, Inhibitory effect of nitric oxide on the induction of cytochrome P450 3A4 mRNA by 1,25-dihydroxyvitamin D3 in Caco-2 cells. Free Radical Research, 33, 279–285.
  • HIDALGO, I. J. and BORCHARDT, R. T., 1990, Transport of bile acids in a human intestinal epithelial cell line, Caco-2. Biochimica et Biophysica Acta, 1035, 97–103.
  • HIDALGO, I. J., RUB, T. J. and BORCHARDT, R. T., 1989, Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96, 736–749.
  • HILGERS, A. R., CONRADI, R. A. and BURTON, P. S., 1990, Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharmaceutical Research, 7, 902–910.
  • HIROHASHI, T., SUZUKI, H., CHU, X. Y., TAMAI, I., TSUJI, A. and SUGIYAMA, Y., 2000, Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). Journal of Pharmacology and Experimental Therapeutics, 292, 265–270.
  • HORVATH, C. M., 2000, STAT proteins and transcriptional responses to extracellular signals. Trends in Biochemical Sciences, 25, 496–502.
  • HOSOYA, K. I., KIM, K. J. and LEE, V. H., 1996, Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers. Pharmaceutical Research, 13, 885–890.
  • Hu, C. and PERLMUTTER, D. H., 1999, Regulation of alphal -antitrypsin gene expression in human intestinal epithelial cell line Caco-2 by HNF-lalpha and HNF-4. American Journal of Physiology, 276, G1181—G1194.
  • Hu, M. and BORCHARDT, R. T., 1992, Transport of a large neutral amino acid in a human intestinal epithelial cell line (Caco-2): uptake and efflux of phenylalanine. Biochimica et Biophysica Acta, 1135, 233–244.
  • KERB, R., HOFFMEYER, S. and BRINKMANN, U., 2001, ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2. Pharmacogenomics, 2, 51–64.
  • KIUCHI, Y., SUZUKI, H., HIROHASHI, T., TYSON, C. A. and SUGIYAMA, Y., 1998, cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3). FEBS Letters, 433, 149–152.
  • LAMPEN, A., BADER, A., BESTMANN, T., WINKLER, M., WITTE, L. and BORLAK, J. T., 1998, Catalytic activities, protein- and mRNA-expression of cytochrome P450 isoenzymes in intestinal cell lines. Xenobiotica, 28, 429–441.
  • LAMPEN, A., MEYER, S. and NAU, H., 2001, Effects of receptor-selective retinoids on CYP26 gene expression and metabolism of all-trans-retinoic acid in intestinal cells. Drug Metabolism and Disposition, 29, 742–747.
  • MA, T. Y., DYER, D. L. and SAID, H. M., 1994, Human intestinal cell line Caco-2: a useful model for studying cellular and molecular regulation of biotin uptake. Biochimica et Biophysica Acta, 1189, 81–88.
  • MESONERO, J., MATOSIN, M., CAMBIER, D., RODRIGUEZ-YOLDI, M. J. and BROT-LAROCHE, E., 1995, Sugar-dependent expression of the fructose transporter GLUTS in Caco-2 cells. Biochemical Journal, 312, 757–762.
  • MORTON, N. M., EMILSSON, V., Liu, Y. L. and CAWTHORNE, M. A., 1998, Leptin action in intestinal cells. Journal of Biological Chemistry, 273, 26194–26201.
  • NEBERT, D. W., ROE, A. L., DIETER, M. Z., SOLIS, W. A., YANG, Y. and DALTON, T. P., 2000, Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochemical Pharmacology, 59, 65–85.
  • NOOTER, K., WESTERMAN, A. M., FLENS, M. J., ZAMAN, G. J., SCHEPER, R. J., VAN WINGERDEN, K. E., BURGER, H., OOSTRUM, R., BOERSMA, T. and SONNEVELD, P., 1995, Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clinical Cancer Research, 1, 1301–1310.
  • PANDREA, I. V., CARRIERE, V., BARBAT, A., CAMBIER, D., DUSSAULX, E., LESUFFLEUR, T., ROUSSET, M. and ZWEIBAUM, A., 2000, Postmitotic differentiation of colon carcinoma Caco-2 cells does not prevent reentry in the cell cycle and tumorigenicity. Experimental and Molecular Pathology, 69, 37–45.
  • PRUEKSARITANONT, T., GORHAM, L. M., HOCHMAN, J. H., TRAN, L. 0. and VYAS, K. P., 1996, Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. Drug Metabolism and Disposition, 24, 634–642.
  • RANALDI, G., ISLAM, K. and SAMBU Y., 1992, Epithelial cells in culture as a model for the intestinal transport of antimicrobial agents. Antimicrobial Agents and Chemotherapy, 36, 1374–1381.
  • RILEY, S. A., WARHURST, G., CROWE, P. T. and TURNBERG, L. A., 1991, Active hexose transport across cultured human Caco-2 cells: characterisation and influence of culture conditions. Biochimica et Biophysica Acta, 1066, 175–182.
  • RODOLOSSE, A., CARRIERE, V., ROUSSET, M. and LACASA, M., 1998, Two HNF-1 binding sites govern the glucose repression of the human sucrase-isomaltase promoter. Biochemical Journal, 336, 115–123.
  • ROSENBERG, D. W. and LEFF, T., 1993, Regulation of cytochrome P450 in cultured human colonic cells. Archives of Biochemistry and Biophysics, 300, 186–192.
  • RUBAS, W., CROMWELL, M. E., SHAHROKH, Z., VILLAGRAN, J., NGUYEN, T. N., WELLTON, M., NGUYEN, T. H. and MRSNY, R. J., 1996, Flux measurements across Caco-2 monolayers may predict transport in human large intestinal tissue. Journal of Pharmaceutical Sciences, 85, 165–169.
  • SCHMIEDLIN-REN, P., THUMMEL, K. E., FISHER, J. M., PAINE, M. F., LOWN, K. S. and WATKINS, P. B., 1997, Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1 alpha,25-dihydroxyvitamin D3. Molecular Pharmacology, 51, 741–754.
  • SCHREM, H., KLEMPNAUER, J. and BORLAK, J., 2002, Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression. Pharmacological Reviews, 54, 129–158.
  • SUAUD, L., JOSEPH, B., FORMSTECHER, P. and LAINE, B., 1997, mRNA expression of HNF-4 isoforms and of HNF-lalpha/HNF-lbeta variants and differentiation of human cell lines that mimic highly specialized phenotypes of intestinal epithelium. Biochemical and Biophysical Research Communications, 235, 820–825.
  • SWENSON, E. S., MANN, E. A., JUMP, M. L. and GIANNELLA, R. A., 1999, Hepatocyte nuclear factor-4 regulates intestinal expression of the guanylin/heat-stable toxin receptor. American Journal of Physiology, 276, G728—G736.
  • TURKSON, J. and JovE, R., 2000, STAT proteins: novel molecular targets for cancer drug discovery. Oncogene, 19, 6613–6626.
  • WANG, S. and EVERS, B. M., 1999, Caco-2 cell differentiation is associated with a decrease in stat protein levels and binding. Journal of Gastrointestinal Surgery, 3, 200–207.
  • WEI, L. Y. and ROEPE, P. D., 1994, Low external pH and osmotic shock increase the expression of human MDR protein. Biochemistry, 33, 7229–7238.
  • WURSTER, A. L., TANAKA, T. and GRUSBY, M. J., 2000, The biology of Stat4 and Stat6. Oncogene, 19, 2577–2584.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.